Lerapolturev Active Not Recruiting Phase 2 Trials for Supratentorial Glioblastoma / Recurrent Glioblastoma / Brain Neoplasm / High Grade Glioma: Glioblastoma (GBM) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04479241LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma